|
Platelet function inhibitors
Citations 241-250 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Clinical Investigations and Reports
Stent Thrombosis in the Modern Era : A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
- Donald E. Cutlip, Donald S. Baim, Kalon K. L. Ho, Jeffrey J. Popma, Alexandra J. Lansky, David J. Cohen, Joseph P. Carrozza, Jr, Manish S. Chauhan, Orlando Rodriguez, and Richard E. Kuntz
Circulation 2001;103:1967-1971
[Abstract]
[Full text]
- Clinical Investigations and Reports
Randomized Trial of Aspirin, Sibrafiban, or Both for Secondary Prevention After Acute Coronary Syndromes
-
Circulation 2001;103:1727-1733
[Abstract]
[Full text]
- Brief Rapid Communications
Testing Platelet Activation With a Shear-Dependent Platelet Function Test Versus Aggregation-Based Tests : Relevance for Monitoring Long-Term Glycoprotein IIb/IIIa Inhibition
- Julio I. Osende, Valentin Fuster, Eli I. Lev, Daichi Shimbo, Ursula Rauch, Jonathan D. Marmur, Merwin Richard, David Varon, and Juan Jose Badimon
Circulation 2001;103:1488-1491
[Abstract]
[Full text]
- Correspondence
Aggrenox and Stress Testing
- Steven R. Bergmann
Circulation 2001;103:e50
[Full text]
- Correspondence
Antithrombotic Effects of Flavonoid
- Shinya Goto and Shunnosuke Handa
Circulation 2001;103:e23
[Full text]
- Clinical Investigations and Reports
Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery
- Deepak L. Bhatt, Derek P. Chew, Alan T. Hirsch, Peter A. Ringleb, Werner Hacke, and Eric J. Topol
Circulation 2001;103:363-368
[Abstract]
[Full text]
- Correspondence
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention • Response
- Dean J. Kereiakes, Steven R. Steinhubl, Kandice Kottke-Marchant, David J. Moliterno, Monique Rosenthal, Eric J. Topol, A. Michael Lincoff, and Barry S. Coller
Circulation 2000;102:e186
[Full text]
- Clinical Investigations and Reports
Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization : Results From the EPILOG Randomized Trial
- A. Michael Lincoff, Daniel B. Mark, James E. Tcheng, Robert M. Califf, Mohan V. Bala, Keaven M. Anderson, Linda Davidson-Ray, J. David Knight, Catherine F. Cabot, and Eric J. Topol
Circulation 2000;102:2923-2929
[Abstract]
[Full text]
- Clinical Investigations and Reports
Enhanced Efficacy of Eptifibatide Administration in Patients With Acute Coronary Syndrome Requiring In-Hospital Coronary Artery Bypass Grafting
- Steven P. Marso, Deepak L. Bhatt, Matthew T. Roe, Penny L. Houghtaling, Marino Labinaz, Neal S. Kleiman, Cornelius Dyke, Maarten L. Simmoons, Robert M. Califf, Robert A. Harrington, and Eric J. Topol
Circulation 2000;102:2952-2958
[Abstract]
[Full text]
- Correspondence
Acute Platelet Inhibition With Abciximab Does Not Reduce In-Stent Restenosis
- Iqbal Malik and Michael Poullis
Circulation 2000;102:110e-a
[Full text]
|
|
